ABC | Volume 110, Nº6, June 2018

Original Article Nascimento et al Cardiovascular disease in Portuguese-speaking countries Arq Bras Cardiol. 2018; 110(6):500-511 Conclusion The data presented show great differences in the relative importance of the burden of CVD in the PSC and indicate that such differences relate to the socioeconomic conditions of the countries. Of the CVD, ischemic heart disease is the major cause of death in all PSC, except for Mozambique and Sao Tome and Principe, where CbVD is the major cause. The PSC share the most relevant risk factors for CVD: hypertension and dietary factors. Genetic factors, implicit in the cultural identity, factors inherent in the host, as well as the huge social inequality might have contributed to explain the mortality rates observed. Collaboration between the PSC might allow sharing successful experiences to confront CVD between those countries. Author contributions Conception and design of the research: Oliveira GMM, Malachias, MVB, Ribeiro AL; Acquisition of data: Reis GMA, Ribeiro AL, Brant LCC, Souza MFM, Malta DC, Teixeira RA; Roth GA; Analysis and interpretation of data: Brant LCC, Reis GMA, Ribeiro AL, Nascimento BR; Statistical analysis: Teixeira RA, Brant LCC, Ribeiro, AL, Roth GA; Obtaining financing: Souza MFM, França E; Writing of the manuscript: Nascimento, BR, Brant, LCC, Oliveira GMM; Critical revision of the manuscript for intellectual content: Todos os autores. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding The Ministry of Health of Brazil was responsible for funding the GBD Brazil Study (Fundo Nacional de Saúde, grant number (17217.9850001 /17-018). Ribeiro was supported in part by CNPq (Bolsa de produtividade em pesquisa, 310679/2016‑8 and IATS, 465518/2014-1) and by FAPEMIG (Programa Pesquisador Mineiro, PPM-00428-17). Study Association This study is not associatedwith any thesis or dissertationwork. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Universidade Federal de Minas Gerais under the protocol number 62803316.7.0000.5149. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 1. WorldHealthOrganization.(WHO).Globalactionplanforthepreventionand controlofnoncommunicablediseases2013-2020.Geneva(Switzerland);2013. 2. Comunidade dos Países de Língua Portuguesa - 2017 (CPLP). [Acesso em 2017 nov 110. Disponível em: https://www.cplp.org/ 3. Institute for HealthNetrics and Evaluation. Global Burden of Disease (GBD). Seattle (WA): University of Washington; 2017. 4. Naghavi M, Abajobir AA, Abaffati C. GBD Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-210. 5. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. 6. GBD DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260-344. 7. RothGA, JohnsonC, Abajobir A, Abd-Allah F, Abera SF, AbyuG, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25. 8. GBD Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970- 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084-150. 9. Murray CJ, Lopez AD. Measuring the global burden of disease. NEngl J Med. 2013;369(5):448-57. 10. França EB, Passos VM, Malta DC, Duncan BB, Ribeiro AL, Guimarães MD, et al. Cause-specific mortality for 249 causes in Brazil and states during 1990-2015: a systematic analysis for the global burden of disease study 2015. Popul Health Metr. 2017;15(1):39. 11. Franca E, de Abreu DX, Rao C, Lopez AD. Evaluation of cause-of-death statistics for Brazil, 2002-2004. Int J Epidemiol. 2008;37(4):891-901. 12. Foreman KJ, Naghavi M, Ezzati M. Improving the usefulness of US mortality data: new methods for reclassification of underlying cause of death. Popul Health Metr. 2016 Apr 28;14:14. 13. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-causemortality, and cause-specificmortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. 14. Salomon JA, Haagsma JA, Davis A, deNoordhout CM, Prolinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712-23. 15. Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, et al. Assessing disabilityweights based on the responses of 30,660 people from four European countries. Popul HealthMetr. 2015Apr 3;13:10. 16. Camões - Instituto da Cooperação e da Lígua. Ministério dos Negócios Estrangeiros; 2017. [Acesso em 2017 nov 22]. Disponível em: http://www. instituto-camoes.pt/ 17. Internet World Stats. Usage and Population Statistics. Miniwatts Marketing Group; 2017. [Accessed in 2017 Nov 22]. Available from: http://www. internetworldstats.com/stats.htm/ 18. Agyepong IA, Sewankambo N, Binagwaho A, Coll-Seck AM, Corrah T, Ezeh A, et al. The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa. Lancet. 2018;390(10114):2803-59. References 509